2023-12-01 2024-11-30 false Capium Accounts Production 1.1 11074075 2023-12-01 2024-11-30 11074075 bus:FullAccounts 2023-12-01 2024-11-30 11074075 bus:FRS102 2023-12-01 2024-11-30 11074075 bus:AuditExemptWithAccountantsReport 2023-12-01 2024-11-30 11074075 bus:SmallCompaniesRegimeForAccounts 2023-12-01 2024-11-30 11074075 bus:PrivateLimitedCompanyLtd 2023-12-01 2024-11-30 11074075 2023-12-01 2024-11-30 11074075 2024-11-30 11074075 bus:RegisteredOffice 2023-12-01 2024-11-30 11074075 core:WithinOneYear 2024-11-30 11074075 core:AfterOneYear 2024-11-30 11074075 1 2023-12-01 2024-11-30 11074075 bus:Director1 2023-12-01 2024-11-30 11074075 bus:Director1 2024-11-30 11074075 bus:Director1 2022-12-01 2023-11-30 11074075 2022-12-01 11074075 bus:LeadAgentIfApplicable 2023-12-01 2024-11-30 11074075 2022-12-01 2023-11-30 11074075 2023-11-30 11074075 core:WithinOneYear 2023-11-30 11074075 core:AfterOneYear 2023-11-30 11074075 bus:EntityAccountantsOrAuditors 2022-12-01 2023-11-30 11074075 bus:OrdinaryShareClass1 2023-12-01 2024-11-30 11074075 bus:OrdinaryShareClass1 2024-11-30 11074075 bus:OrdinaryShareClass1 2022-12-01 2023-11-30 11074075 bus:OrdinaryShareClass1 2023-11-30 11074075 core:NetGoodwill 2023-12-01 2024-11-30 11074075 core:CostValuation core:Non-currentFinancialInstruments 2024-11-30 11074075 core:CostValuation core:Non-currentFinancialInstruments 2023-11-30 11074075 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-11-30 11074075 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-11-30 11074075 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-11-30 11074075 core:Non-currentFinancialInstruments 2024-11-30 11074075 core:Non-currentFinancialInstruments 2023-11-30 11074075 core:ShareCapital 2024-11-30 11074075 core:ShareCapital 2023-11-30 11074075 core:RetainedEarningsAccumulatedLosses 2024-11-30 11074075 core:RetainedEarningsAccumulatedLosses 2023-11-30 11074075 dpl:Item1 2023-12-01 11074075 dpl:Item1 2024-11-30 11074075 dpl:Item1 2022-12-01 11074075 dpl:Item1 2023-11-30 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 11074075
England and Wales

 

 

 

SURGICAL ENTERPRISES LTD


Unaudited Filleted Financial Statements
 


Period of accounts

Start date: 01 December 2023

End date: 30 November 2024
Director Kalliatchali Janardhanan
Registered Number 11074075
Registered Office 18 Barking Road
London
E6 3BP
Accountants ASR Accountancy Ltd
18 Barking Road
London
E6 3BP
1
You consider that the company is exempt from an audit for the year ended 30 November 2024 . You have acknowledged, on the balance sheet, your responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts. These responsibilities include preparing accounts that give a true and fair view of the state of affairs of the company at the end of the financial year and of its profit or loss for the financial year.
In accordance with your instructions, we have prepared the accounts which comprise the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the accounting records of the company and on the basis of information and explanations you have given to us.
We have not carried out an audit or any other review, and consequently we do not express any opinion on these accounts. 



....................................................
ASR Accountancy Ltd
18 Barking Road
London
E6 3BP
10 April 2025
2
 
 
Notes
 
2024
£
  2023
£
Current assets      
Cash at bank and in hand 32,903    32,699 
Creditors: amount falling due within one year 3 (33,273)   (32,973)
Net current assets (370)   (274)
 
Total assets less current liabilities (370)   (274)
Net assets (370)   (274)
 

Capital and reserves
     
Called up share capital 4 1    1 
Profit and loss account (371)   (275)
Shareholders' funds (370)   (274)
 


For the year ended 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the director on 10 April 2025 and were signed by:


-------------------------------
Kalliatchali Janardhanan
Director
3
General Information
Surgical Enterprises Ltd is a private company, limited by shares, registered in England and Wales, registration number 11074075, registration address 18 Barking Road, London, E6 3BP.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Kalliatchali JanardhananPage 3Statement of compliance
These financial statements have been prepared in compliance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared on the going concern basis and under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, 
Research and development expenditure
Research and development expenditure is charged to the income statement in the period in which it is incurred.
Website cost
Planning and operating costs for the company's website are charged to the income statement as incurred.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Dividends
Proposed dividends are only included as liabilities in the statement of financial position when their payment has been approved by the shareholders prior to the statement of financial position date.
Goodwill
Acquired goodwill is stated at cost less amortisation. Amortisation is calculated on a straight line basis over the estimated expected useful economic life of the goodwill of years.
2.

Average number of employees

which comprise the Profit and Loss Account, the Balance Sheet and the related notesPage 3Loss
Average number of employees during the year was 1 (2023 : 1).
3.

Creditors: amount falling due within one year

2024
£
  2023
£
Directors' Current Accounts 33,273    32,973 
33,273    32,973 

4.

Share Capital

Allotted, called up and fully paid
2024
£
  2023
£
1 Class A share of £1.00 each  
 

4